1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-D2448 Cy3-PEG-Thiol

Fluorescent Dye

Cancer

2025-01 Cy3-PEG-Thiol
HY-N6959 Osmundacetone

紫萁酮

Reactive Oxygen Species; Apoptosis

Metabolic Disease

2025-01 Osmundacetone
HY-159852 BBO-10203

PI3K; Akt

Cancer

2025-01 BBO-10203
HY-D0967 Cy5-bifunctional dye

花氰染料Cy5

Fluorescent Dye

Others

2025-01 Cy5-bifunctional dye
HY-W141374 CB096

DNA/RNA Synthesis

Neurological Disease

2025-01 CB096
HY-129861 5'-Ethynyl-2'-deoxycytidine

HSV

Cancer;

Infection

2025-01 5'-Ethynyl-2'-deoxycytidine
HY-P10713 PTZ-GFFY

Others

Others

2025-01 PTZ-GFFY
HY-170533 NLRP3-IN-64

NOD-like Receptor (NLR)

Inflammation/Immunology

2025-01 NLRP3-IN-64
HY-170532 NLRP3-IN-63

NOD-like Receptor (NLR)

Inflammation/Immunology;

Neurological Disease

2025-01 NLRP3-IN-63
HY-170419 APJ receptor agonist 10

Apelin Receptor (APJ)

Cardiovascular Disease

2025-01 APJ receptor agonist 10
HY-129824 3-Methyl orsellinic acid

3-甲基苔色酸

Endogenous Metabolite

Neurological Disease

2025-01 3-Methyl orsellinic acid
HY-170512 Mal-GGFG-PAB-MMAE

Drug-Linker Conjugates for ADC

Cancer

2025-01 Mal-GGFG-PAB-MMAE
HY-170529 NLRP3-IN-61

NOD-like Receptor (NLR); Pyroptosis

Inflammation/Immunology

2025-01 NLRP3-IN-61
HY-170530 NLRP3-IN-62

NOD-like Receptor (NLR); Pyroptosis

Inflammation/Immunology

2025-01 NLRP3-IN-62
HY-164840 Clofarabine-5'-triphosphate

DNA/RNA Synthesis

Cancer

2025-01 Clofarabine-5'-triphosphate
HY-111766 YD-3

Thrombin

Cardiovascular Disease

2025-01 YD-3
HY-164781 KOTX1

Aldehyde Dehydrogenase (ALDH)

Metabolic Disease

2025-01 KOTX1
HY-N0572 9-Hydroxycamptothecin

Drug Derivative

Cancer

2025-01 9-Hydroxycamptothecin
HY-124176 L-6355

Phosphodiesterase (PDE); Calmodulin

Cardiovascular Disease

2025-01 L-6355
HY-170351 NH2-PEG2-OMs

PROTAC Linkers

Cancer

2025-01 NH2-PEG2-OMs